Available Until 2/25/2029

Beyond LDL-C: Lipoprotein(a), Apolipoprotein B, and the Next Wave of Cardiovascular Risk Reduction

ACPE Activity Number: 0204-0000-26-043-H01-P
Release Date: 2/25/2026
Expiration Date: 2/25/2029
Activity Type: Knowledge-based
CE Credits: 1 contact hour
Activity Fee: Member – Free / Non-Member – Not Available

This activity is a recording of a live webinar, if you claimed credit for the live activity, you should not claim credit for this activity.

Activity Overview 

Despite advances in lipid-lowering therapy, many patients remain at high risk for atherosclerotic cardiovascular disease. This educational session will examine the evolving role of lipoprotein(a) and apolipoprotein B in risk assessment and highlight novel therapies in development that directly target lipoprotein(a). The webinar will emphasize implications for health-system pharmacists as these therapies move closer to clinical practice.